We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Global Network Improves Access to Diagnostic Insights

By HospiMedica International staff writers
Posted on 24 Oct 2018
Quest Diagnostics (Madison, NJ, USA), a leading provider of diagnostic information services, together with other diagnostic services providers, have announce the formation and launch of the Global Diagnostics Network (GDN), a strategic working group of diagnostic laboratories, each committed to unleashing and sharing local innovation to increase global access to diagnostic science, information, and services in order to improve the delivery of global healthcare.

GDN initiatives will benefit patients, healthcare providers, referring practitioners, pharmaceutical innovators, government agencies, non-governmental organizations (NGOs), and academic institutions. Starting priority areas of focus include a global launch platform for high quality companion diagnostics and the creation of an emerging pathogen preparedness network in order to expedite infectious disease research and response. Additional initiatives will be rolled out based on regional and global priorities.

“The Global Diagnostics Network will help solve some of the world's most pressing healthcare challenges by enabling fast and consistent access to leading diagnostic innovations and best practices,” said Steve Rusckowski, chairman, president, and CEO of Quest Diagnostics. “As we met with regional lab leaders over the past year, it became clear that we can accelerate the development and delivery of advanced diagnostics and diagnostic insights by bringing together our peers and sharing best practices.”

“The GDN collaboration will open up new opportunities by removing silos around unique knowledge and resources,” said Carrie Eglinton Manner, senior VP of advanced diagnostics at Quest Diagnostics. “We see this as a pragmatic approach to driving growth and excellence for all network members, while providing customers global access to innovations in diagnostics science, information, and service delivery.”

In addition to Quest Diagnostics, charter members of the GDN are Al Borg Medical Laboratories (Jeddah, Saudi Arabia), Dasa (Sao Paolo, Brazil), GC Labs (Yongin-Si, South Korea), KingMed Diagnostics (Hong Kong, China), Primary Health Care (Sydney, Australia), and SYNLAB (Munich, Germany).

Related Links:
Quest Diagnostics
Global Diagnostics Network


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Surgical Positioning Accessory
Lateral Support Curved Short (10-360)
New
Vacuum-Assisted Breast Biopsy Device
Celero

Latest Health IT News

Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors

Smartwatches Could Detect Congestive Heart Failure

Versatile Smart Patch Combines Health Monitoring and Drug Delivery